Try our beta test site
168 studies found for:    Open Studies | "Pharyngeal Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122)
Condition: Nasopharyngeal Neoplasms
Interventions: Biological: Pembrolizumab;   Drug: Capecitabine;   Drug: Gemcitabine;   Drug: Docetaxel
22 Recruiting Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China
Condition: Nasopharyngeal Cancinoma (NPC)
Intervention:
23 Recruiting Hyperfractionated Intensity-modulated Radiotherapy (IMRT) Versus Conventional Fraction IMRT for Patients With Loco-regionally Recurrent Nasopharyngeal Carcinoma.
Conditions: Nasopharyngeal Neoplasms;   Mortality;   Quality of Life;   Complications
Interventions: Radiation: Hyperfractionated IMRT;   Radiation: Conventional Fraction IMRT
24 Recruiting Improving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance
Condition: Oropharyngeal Cancer
Intervention: Other: Intraoperative CT imaging
25 Not yet recruiting Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
Condition: Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
Interventions: Drug: Cisplatin;   Radiation: Postoperative radiotherapy
26 Recruiting Hemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Neoplasms;   Blood Cell Count;   Neoplasm Staging;   Prognosis
Intervention:
27 Not yet recruiting The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Condition: Effects of Chemotherapy
Interventions: Drug: Concurrent chemotherapy with cisplatin;   Radiation: Intensity modulated radiotherapy
28 Recruiting Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
Conditions: Oropharyngeal Cancer;   Hypopharyngeal Cancer
Interventions: Drug: docetaxel and cisplatin;   Radiation: IMRT;   Biological: Nimotuzumab
29 Recruiting Screening for Nasopharyngeal Carcinoma in High Risk Populations
Conditions: Nasopharyngeal Cancer;   Screening
Intervention:
30 Not yet recruiting A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients
Condition: Malignant Neoplasm of Nasopharynx
Intervention: Dietary Supplement: Nutrison
31 Recruiting A Pilot Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck
Conditions: Oropharyngeal Neoplasms;   Head and Neck Cancer
Intervention: Device: Transoral Robotic Surgery (TORS) with the daVinci Robotic Surgical System device
32 Recruiting Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients
Conditions: Oral Cavity Cancer;   Oropharyngeal Cancer;   Lymphedema;   Fibrosis
Interventions: Other: LEF measures;   Procedure: Technical measure
33 Recruiting Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck
Condition: Head And Neck Cancer
Interventions: Radiation: Intensity-Modulated X-Ray Therapy (IMRT);   Radiation: Intensity-Modulated Proton Beam Therapy (IMPT);   Procedure: Modified barium swallow (MBS);   Behavioral: Questionnaires
34 Recruiting Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Diagnostic Test: Plasma EBV DNA
35 Not yet recruiting IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Intensity modulated radiotherapy;   Drug: Cisplatin
36 Recruiting Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Radiotherapy alone;   Radiation: Concurrent chemoradiotherapy
37 Not yet recruiting Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer
Conditions: Stage 0 Nasopharyngeal Carcinoma;   Stage 0 Paranasal Sinus Cancer;   Stage I Nasopharyngeal Carcinoma;   Stage I Paranasal Sinus Cancer;   Stage II Nasopharyngeal Carcinoma;   Stage II Paranasal Sinus Cancer;   Stage IIA Nasopharyngeal Carcinoma;   Stage IIB Nasopharyngeal Carcinoma;   Stage III Nasopharyngeal Carcinoma;   Stage III Paranasal Sinus Cancer;   Stage IV Nasopharyngeal Carcinoma;   Stage IV Paranasal Sinus Cancer;   Stage IVA Nasopharyngeal Carcinoma;   Stage IVA Paranasal Sinus Cancer;   Stage IVB Nasopharyngeal Carcinoma;   Stage IVB Paranasal Sinus Cancer;   Stage IVC Nasopharyngeal Carcinoma;   Stage IVC Paranasal Sinus Cancer
Interventions: Other: Physiologic Testing;   Other: Quality-of-Life Assessment;   Procedure: Sham Intervention;   Procedure: Therapeutic Procedure;   Drug: rose essential oil;   Drug: lemon essential oil;   Drug: clove essential oil;   Drug: eucalyptus essential oil;   Drug: canola oil placebo
38 Recruiting Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Nimotuzumab;   Radiation: Radiation
39 Not yet recruiting Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Other: laboratory biomarker analysis
40 Not yet recruiting Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma;   Children
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Drug: 5-fu;   Radiation: Radical radiotherapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.